29.4 C
Chennai
November 21, 2024
Special features

At Compamed, TekniPlex Healthcare to Highlight Concept-to-Commercialization Capabilities for Class III Implantable Devices and Delivery Systems

Start-to-finish services include precision, tight-tolerance metalworking expertise and injection molding solutions; company also will display new bio-based PVC compounds and its strongest-ever reinforced paper for med device packaging.

TekniPlex Healthcare, which utilizes advanced materials science expertise to help deliver better patient outcomes, will emphasize its significantly broadened capabilities for the design and manufacture of Class III implantable devices and delivery systems at Compamed, November 11-14 in Düsseldorf, Germany. At Hall 8b, Stand N02, the company will highlight its status as a full-fledged CDMO in these niches, one capable of partnering with startups and established entities alike on everything from initial concepting, prototyping and pilot production through larger-scale manufacturing and commercialization. The company also will showcase several recently introduced solutions, including bio-based PVC compounds and its most robust reinforced paper to date for medical device packaging applications.

Expanded Upstream Capabilities for Medical Device Development

TekniPlex Healthcare is among the few medical device CDMOs offering comprehensive, ideation-to-completion product creation across a wide range of categories including endovascular stents, heart valves and delivery systems. Among other differentiators, the company offers high-precision, tight-tolerance development and prototyping for the mission critical metal components typical not only in cardiovascular settings but also pulmonary, gastrointestinal, laparoscopic and other endoscopic applications – including devices for delivering chemotherapy drugs.

TekniPlex Healthcare now offers an array of services supporting customers from early ideation stages through product development, prototyping, clinical trials, testing, new product introduction and full production of catheter-based systems and other tubing-related solutions. This includes an array of precision secondary processes, as well as clean room assembly of Class II and Class III devices such as stents, heart valves, catheter-based devices and delivery systems.

Bio-based Compounds for Medical Plastics Applications

TekniPlex Healthcare has become the first healthcare solutions company to introduce bio-based compounds for medical plastics applications whose performance and compositional properties are equivalent to conventional polyvinyl chloride (PVC) resins. Certified through the globally recognized International Sustainability & Carbon Certification PLUS (ISCC PLUS) system, the bio-based medical-grade PVC compounds utilize resins and plasticizers manufactured with renewable energy and bio-attributed classification.​ The compounds are equivalent to traditional medical-grade PVC in terms of chemical composition, functionality and regulatory viability.

The bio-based, medical-grade PVC compounds enhance sustainability profiles without sacrificing the reliable performance for which traditional PVC compounds are known. Conveniently, the resins are drop-in replacements for a wide variety of injection molded or extruded PVC compounds utilized in a broad array of applications, including tubing solutions such as IV therapy tube sets, drip chambers, and peristaltic pump tubing; films used for trays, pouches, bags and other form-fill-seal settings; and other components composed of medical-grade plastics.

Related posts

The future for PVC cabling – recyclability and circularity

polymartadmin